In contrast to mature normal leukocytes, CLL cells express on their surface ROR1, a tyrosine-kinase-like transmembrane receptor whose higher expression level has been associated with a worse patient’s outcome (Cui et al., 2016). Here, ROR1 is linked to B-cell chronic lymphocytic leukemia.